Experiences of dysmenorrhea and its treatment among allistic and autistic menstruators: a thematic analysis.


Journal

BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690

Informations de publication

Date de publication:
25 05 2023
Historique:
received: 02 12 2022
accepted: 17 04 2023
medline: 29 5 2023
pubmed: 26 5 2023
entrez: 25 5 2023
Statut: epublish

Résumé

Dysmenorrhea (i.e., period pain) is common and debilitating. Autistic people are known to experience pain differently, yet little is known about the menstrual pain experiences of autistic menstruators relative to non-autistic peers. This study aimed to explore the experience of period pain and treatment uptake for period pain among allistic and autistic populations. This study used a qualitative design and opportunity sampling approach. Thirty-seven participants (of whom 17 were autistic) were interviewed via video-conferencing software using a semi-structured topic guide. Transcriptions of interviews were analysed using Braun and Clarke's Reflexive Thematic Analysis. Data were initially analysed together for common themes. Autistic menstruators' data was subsequently analysed separately to elucidate the unique experiences of this group. A total of six themes were constructed from the data. Initial analysis determined three themes related to experiences of period pain and treatment uptake in both allistic and autistic menstruators. Social perception of menstruation was discussed, highlighting the normalisation of pain, the taboo nature, and gendered experience of menstruation, contributing to untreated menstrual pain. Issues within menstrual healthcare were also shared, including experiences of ineffective treatment, dismissive interactions, and insufficient menstrual education. Impaired functionality was repeatedly highlighted, with menstruators detailing significant limitations to their usual functioning due to menstrual pain and ineffective treatment. Three further themes were constructed from separate analysis of data from autistic menstruators. Autistic menstruators discussed the impact of menstruation on their sensory experiences and needs, with many identifying overstimulation during menstruation. Social exclusion was discussed as a factor contributing to the experience of menstrual pain and poor treatment uptake. The final theme identified pain communication differences between autistic and allistic menstruators resulting in reports of ineffective treatment and challenges in healthcare interactions. Communication differences, sensory aspects, and social factors contributed to the experience of period pain and treatment uptake for autistic menstruators. The perception of menstruation within society was highlighted by allistic and autistic menstruators as influential to their pain experience and engagement with treatment. Functionality was significantly impacted by pain for this sample. The study highlights societal and healthcare factors that could be improved to ensure accessibility of support and treatment for menstrual issues.

Sections du résumé

BACKGROUND
Dysmenorrhea (i.e., period pain) is common and debilitating. Autistic people are known to experience pain differently, yet little is known about the menstrual pain experiences of autistic menstruators relative to non-autistic peers. This study aimed to explore the experience of period pain and treatment uptake for period pain among allistic and autistic populations.
METHODS
This study used a qualitative design and opportunity sampling approach. Thirty-seven participants (of whom 17 were autistic) were interviewed via video-conferencing software using a semi-structured topic guide. Transcriptions of interviews were analysed using Braun and Clarke's Reflexive Thematic Analysis. Data were initially analysed together for common themes. Autistic menstruators' data was subsequently analysed separately to elucidate the unique experiences of this group.
RESULTS
A total of six themes were constructed from the data. Initial analysis determined three themes related to experiences of period pain and treatment uptake in both allistic and autistic menstruators. Social perception of menstruation was discussed, highlighting the normalisation of pain, the taboo nature, and gendered experience of menstruation, contributing to untreated menstrual pain. Issues within menstrual healthcare were also shared, including experiences of ineffective treatment, dismissive interactions, and insufficient menstrual education. Impaired functionality was repeatedly highlighted, with menstruators detailing significant limitations to their usual functioning due to menstrual pain and ineffective treatment. Three further themes were constructed from separate analysis of data from autistic menstruators. Autistic menstruators discussed the impact of menstruation on their sensory experiences and needs, with many identifying overstimulation during menstruation. Social exclusion was discussed as a factor contributing to the experience of menstrual pain and poor treatment uptake. The final theme identified pain communication differences between autistic and allistic menstruators resulting in reports of ineffective treatment and challenges in healthcare interactions.
CONCLUSIONS
Communication differences, sensory aspects, and social factors contributed to the experience of period pain and treatment uptake for autistic menstruators. The perception of menstruation within society was highlighted by allistic and autistic menstruators as influential to their pain experience and engagement with treatment. Functionality was significantly impacted by pain for this sample. The study highlights societal and healthcare factors that could be improved to ensure accessibility of support and treatment for menstrual issues.

Identifiants

pubmed: 37231369
doi: 10.1186/s12905-023-02370-8
pii: 10.1186/s12905-023-02370-8
pmc: PMC10214564
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

288

Informations de copyright

© 2023. The Author(s).

Références

Acta Obstet Gynecol Scand Suppl. 1979;87:27-32
pubmed: 380250
JBRA Assist Reprod. 2019 Jan 31;23(1):51-57
pubmed: 30521155
J Womens Health (Larchmt). 2021 Sep;30(9):1334-1343
pubmed: 33026968
Lancet Child Adolesc Health. 2018 Aug;2(8):e17
pubmed: 30119723
Pain Med. 2021 Dec 11;22(12):2835-2845
pubmed: 33822197
Complement Ther Clin Pract. 2017 May;27:5-10
pubmed: 28438280
Qual Life Res. 2017 Aug;26(8):2041-2055
pubmed: 28405780
Medicine (Baltimore). 2018 Jun;97(23):e11007
pubmed: 29879061
Healthcare (Basel). 2022 Jan 14;10(1):
pubmed: 35052320
Neuropsychiatr Dis Treat. 2016 Sep 12;12:2319-25
pubmed: 27672325
J Pediatr Adolesc Gynecol. 2020 Jun;33(3):278-284
pubmed: 31765795
BMC Womens Health. 2018 Mar 2;18(1):47
pubmed: 29499683
Health Commun. 2023 Apr;38(4):834-843
pubmed: 34544296
J Psychosom Obstet Gynaecol. 2019 Sep;40(3):185-194
pubmed: 29745745
Horm Behav. 2017 Nov;96:69-83
pubmed: 28919554
JAMA. 2020 Jan 21;323(3):268-269
pubmed: 31855238
Pediatr Clin North Am. 2017 Apr;64(2):331-342
pubmed: 28292449
Am Fam Physician. 1999 Aug;60(2):489-96
pubmed: 10465224
Am J Obstet Gynecol. 2018 Apr;218(4):390-400
pubmed: 28888592
Hum Reprod Update. 2015 Nov-Dec;21(6):762-78
pubmed: 26346058
Med Teach. 2022 Apr 7;:1-11
pubmed: 35389310
J Adolesc Health. 2011 Oct;49(4):443-5
pubmed: 21939879
Evid Based Complement Alternat Med. 2018 Nov 21;2018:8791538
pubmed: 30584456
Gynecol Obstet Invest. 2019;84(3):209-224
pubmed: 30630172
Rev J Autism Dev Disord. 2021;8(4):454-470
pubmed: 34868805
Cochrane Database Syst Rev. 2016 Apr 18;4:CD007854
pubmed: 27087494
Am Fam Physician. 2021 Aug 1;104(2):164-170
pubmed: 34383437
Autism. 2016 May;20(4):483-95
pubmed: 26111537
BMJ. 2006 May 13;332(7550):1134-8
pubmed: 16690671
Evid Based Complement Alternat Med. 2015;2015:735690
pubmed: 26346199
Obstet Gynecol. 2022 Mar 1;139(3):407-416
pubmed: 35115434
BMC Womens Health. 2021 Nov 8;21(1):392
pubmed: 34749716
Holist Nurs Pract. 2021 Nov-Dec 01;35(6):306-314
pubmed: 34647912
Epidemiol Rev. 2014;36:104-13
pubmed: 24284871
J Pain Res. 2017 May 09;10:1079-1085
pubmed: 28533696
Am J Obstet Gynecol. 2020 Sep;223(3):415.e1-415.e16
pubmed: 32112731
BMC Womens Health. 2022 Oct 5;22(1):407
pubmed: 36199106
Korean J Fam Med. 2022 Mar;43(2):101-108
pubmed: 35320895
Clin J Pain. 2004 Mar-Apr;20(2):88-97
pubmed: 14770048
Acta Biomed. 2017 Jan 16;87(3):233-246
pubmed: 28112688
J Womens Health (Larchmt). 2019 Aug;28(8):1161-1171
pubmed: 31170024
Int J Womens Health. 2021 Mar 17;13:327-336
pubmed: 33762855
J Pediatr Adolesc Gynecol. 2020 Jun;33(3):285-290
pubmed: 31883905
Br J Pain. 2021 Aug;15(3):345-356
pubmed: 34377460
Int J Environ Res Public Health. 2020 Sep 05;17(18):
pubmed: 32899505
F1000Res. 2017 Sep 5;6:1645
pubmed: 28944048
Aust J Rural Health. 2011 Aug;19(4):218-23
pubmed: 21771164
J Midwifery Womens Health. 2018 Jul;63(4):470-482
pubmed: 29902363
F1000Res. 2018 Jan 16;7:59
pubmed: 30228874
Health Care Women Int. 2007 May;28(5):453-77
pubmed: 17469000
J Autism Dev Disord. 2019 Jan;49(1):270-278
pubmed: 30264376
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
PLoS One. 2019 Jul 24;14(7):e0220103
pubmed: 31339951
Pediatr Endocrinol Rev. 2015 Dec;13(2):512-20
pubmed: 26841639
Clin Teach. 2020 Dec;17(6):596-599
pubmed: 32790137
Autism Adulthood. 2021 Sep 1;3(3):209-220
pubmed: 36605367
Curr Probl Pediatr Adolesc Health Care. 2022 May;52(5):101186
pubmed: 35523674
Am J Pharm Educ. 2020 Jan;84(1):7120
pubmed: 32292186
J Chiropr Med. 2005 Spring;4(2):76-88
pubmed: 19674650
Nurs Open. 2022 Nov;9(6):2908-2914
pubmed: 34302437
J Autism Dev Disord. 2016 May;46(5):1793-805
pubmed: 26810436
Autism. 2015 May;19(4):387-99
pubmed: 24687688
Turk J Obstet Gynecol. 2020 Sep;17(3):196-201
pubmed: 33072424

Auteurs

Lauren J Gray (LJ)

Division of Psychology, Faculty of Natural Sciences, University of Stirling, Stirling, Scotland.
Department of Psychology, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland.

Hannah Durand (H)

Division of Psychology, Faculty of Natural Sciences, University of Stirling, Stirling, Scotland. hannah.durand@stir.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH